Press Releases on September 17, 2018 - EIN Presswire - Press Release Distribution Service

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Lenalidomide Accord, lenalidomide, Multiple Myeloma, Date of ...

Multiple myeloma Lenalidomide Accord as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. Lenalidomide Accord as combination therapy with …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Lenalidomide Accord, lenalidomide, Multiple Myeloma, Date of ...

Multiple myeloma Lenalidomide Accord as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. Lenalidomide Accord as combination therapy with …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Irbesartan Teva, irbesartan, Hypertension, Date of authorisation: 30/10/...

Irbesartan Teva is taken by mouth, with or without food. The usual recommended dose is 150 mg once a day. If the blood pressure is not sufficiently controlled, the dose can be increased to 300 mg a day or other medicines for hypertension can be added, such …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Irbesartan Teva, irbesartan, Hypertension, Date of authorisation: 30/10/...

Irbesartan Teva is taken by mouth, with or without food. The usual recommended dose is 150 mg once a day. If the blood pressure is not sufficiently controlled, the dose can be increased to 300 mg a day or other medicines for hypertension can be added, such …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Kymriah,tisagenlecleucel, decision type: , therapeutic area: , PIP ...

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Prometax, rivastigmine, Alzheimer Disease;Parkinson Disease;Dementia, ...

Treatment with Prometax should be initiated and supervised by a doctor who has experience in the diagnosis and treatment of Alzheimer’s disease or dementia in patients with Parkinson’s disease. Treatment should only be started if a caregiver is available …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Prometax, rivastigmine, Alzheimer Disease;Parkinson Disease;Dementia, ...

Treatment with Prometax should be initiated and supervised by a doctor who has experience in the diagnosis and treatment of Alzheimer’s disease or dementia in patients with Parkinson’s disease. Treatment should only be started if a caregiver is available …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Cancidas (previously Caspofungin MSD), caspofungin, Candidiasis;...

Studies show that Cancidas treatment can lead to favourable responses in patients with fungal infections, including improvement of symptoms and the clearing of fungus from patient’s body. In a study of 239 adults with invasive candidiasis, 73% of the …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Cancidas (previously Caspofungin MSD), caspofungin, Candidiasis;...

Studies show that Cancidas treatment can lead to favourable responses in patients with fungal infections, including improvement of symptoms and the clearing of fungus from patient’s body. In a study of 239 adults with invasive candidiasis, 73% of the …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva, emtricitabine,tenofovir ...

Treatment of HIV-1 infection Emtricitabine/Tenofovir disoproxil Zentiva is indicated in antiretroviral combination therapy for the treatment of HIV-1 infected adults. Emtricitabine/Tenofovir disoproxil Zentiva is also indicated for the treatment of HIV-1 …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva, emtricitabine,tenofovir ...

Treatment of HIV-1 infection Emtricitabine/Tenofovir disoproxil Zentiva is indicated in antiretroviral combination therapy for the treatment of HIV-1 infected adults. Emtricitabine/Tenofovir disoproxil Zentiva is also indicated for the treatment of HIV-1 …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Vimpat,lacosamide, decision type: , therapeutic area: , PIP number: P/...

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Levetiracetam Accord, levetiracetam, Epilepsy, Date of authorisation: 03/...

Levetiracetam is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. Levetiracetam is indicated as adjunctive therapy: in the treatment …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Levetiracetam Accord, levetiracetam, Epilepsy, Date of authorisation: 03/...

Levetiracetam is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. Levetiracetam is indicated as adjunctive therapy: in the treatment …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Sylvant, siltuximab, Giant Lymph Node Hyperplasia, Date of authorisation:...

Sylvant is a medicine that is used to treat multicentric Castleman’s disease in adults who are not infected with human immunodeficiency virus (HIV) and human herpesvirus-8 (HHV-8). Castleman’s disease is a disorder of the lymphatic system (a network of …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Sylvant, siltuximab, Giant Lymph Node Hyperplasia, Date of authorisation:...

Sylvant is a medicine that is used to treat multicentric Castleman’s disease in adults who are not infected with human immunodeficiency virus (HIV) and human herpesvirus-8 (HHV-8). Castleman’s disease is a disorder of the lymphatic system (a network of …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Komboglyze, saxagliptin,metformin hydrochloride, Diabetes Mellitus, Type ...

Komboglyze is indicated as an adjunct to diet and exercise to improve glycaemic control in adult patients aged 18 years and older with type-2 diabetes mellitus inadequately controlled on their maximally tolerated dose of metformin alone or those already …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Human medicines European public assessment report (EPAR): Komboglyze, saxagliptin,metformin hydrochloride, Diabetes Mellitus, Type ...

Komboglyze is indicated as an adjunct to diet and exercise to improve glycaemic control in adult patients aged 18 years and older with type-2 diabetes mellitus inadequately controlled on their maximally tolerated dose of metformin alone or those already …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:07 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Otezla,apremilast, decision type: , therapeutic area: , PIP number: P/...

Treatment of chronic idiopathic arthritis (including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and juvenile idiopathic arthritis)

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:06 GMT

Human medicines European public assessment report (EPAR): Opsumit, macitentan, Hypertension, Pulmonary, Date of authorisation: 20/...

Opsumit is a medicine used for the long-term treatment of pulmonary arterial hypertension (PAH). PAH is a condition in which there is abnormally high blood pressure in the arteries of the lungs, causing symptoms such as breathlessness and fatigue. Opsumit …

Distribution channels: Healthcare & Pharmaceuticals Industry